Cogent Biosciences (COGT) Other Working Capital Changes (2017 - 2021)
Historic Other Working Capital Changes for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $1.7 million.
- Cogent Biosciences' Other Working Capital Changes rose 23017.71% to $1.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.7 million, marking a year-over-year increase of 15353.74%. This contributed to the annual value of $4.3 million for FY2024, which is 64447.24% up from last year.
- According to the latest figures from Q4 2021, Cogent Biosciences' Other Working Capital Changes is $1.7 million, which was up 23017.71% from $66000.0 recorded in Q3 2021.
- Cogent Biosciences' Other Working Capital Changes' 5-year high stood at $3.4 million during Q2 2021, with a 5-year trough of -$13.4 million in Q4 2019.
- Its 5-year average for Other Working Capital Changes is -$957800.0, with a median of -$820500.0 in 2017.
- In the last 5 years, Cogent Biosciences' Other Working Capital Changes tumbled by 52714.09% in 2019 and then skyrocketed by 39017.47% in 2020.
- Cogent Biosciences' Other Working Capital Changes (Quarter) stood at -$1.3 million in 2017, then plummeted by 65.27% to -$2.1 million in 2018, then crashed by 527.14% to -$13.4 million in 2019, then surged by 90.31% to -$1.3 million in 2020, then soared by 230.18% to $1.7 million in 2021.
- Its Other Working Capital Changes was $1.7 million in Q4 2021, compared to $66000.0 in Q3 2021 and $3.4 million in Q2 2021.